Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gelatin from BSE countries used in oral products exempt from FDA restrictions.

This article was originally published in The Tan Sheet

Executive Summary

GELATIN FROM BSE COUNTRIES USED IN ORAL PRODUCTS EXEMPT FROM FDA RESTRICTIONS on the use of bovine-derived materials, under an agency guidance announced in the Oct. 7 Federal Register. "There does not appear to be a basis for objection to the use of gelatin in FDA-regulated products for oral consumption and cosmetic use by humans when the gelatin is produced from bones obtained from cattle residing in, or originating from," countries where there are bovine spongiform encephalopathies "if the cattle come from BSE-free herds and if the slaughterhouse removes the heads, spines and spinal cords directly after slaughter," the guidance states.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087629

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel